138 results
8-K
EX-3.2
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
, or if a majority of Disinterested Directors so directs, by independent legal counsel in a written opinion, or (d) by the stockholders of the Corporation … . The failure of the Corporation (including its Board of Directors or any committee thereof, independent legal counsel, or stockholders) to make
SC 14D9/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Tender offer solicitation (amended)
8:14am
radiographic progression-free survival (rPFS) per blinded independent central review of 9.5 months for patients treated with 177Lu-PNT2002, compared
SC 14D9/A
PNT
POINT Biopharma Global Inc.
1 Nov 23
Tender offer solicitation (amended)
4:40pm
with the assistance of, or reviewed, compiled or examined by, independent accountants. The Projections are not being included in this Schedule 14D-9 to influence any
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
of the POINT Board and with the assistance of independent financial and legal advisors. The POINT Board also considered that this process created a competitive … .
Centerview assumed, without independent verification or any responsibility therefor, the accuracy and completeness of the financial, legal, regulatory
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
, including Regulation S-X promulgated under the Securities Act of 1933, as amended, in each case, as agreed to by POINT’s independent public … with outside counsel and its independent financial advisor, (A) is more favorable from a financial point of view to the stockholders of POINT than
SC TO-T
EX-99
zqycf4b66n5 92jie
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
EX-99.3
6hlm57t0qzrp33wx53
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-99.2
iagr emgid
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-2.1
cp73e6xx
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
sj76r8 ksv4
3 Oct 23
Tender and Support Agreement
7:35am
S-8
EX-23.2
yeytu
14 Aug 23
Registration of securities for employees
10:22am
8-K
w2s72m0nte1j
3 Aug 23
Changes in Registrant's Certifying Accountant
4:05pm
8-K
yintoy314l5 itsf4g8
13 Jun 23
Departure of Directors or Certain Officers
4:45pm
8-K
tbv47rod
5 Jun 23
Submission of Matters to a Vote of Security Holders
4:07pm
ARS
1wnk fb5v343nsajj
1 May 23
Annual report to shareholders
1:52pm